Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Lymphocytic Bronchiolitis After Lung Transplantation
NCT01109160Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Apr 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin in Lymphocytic bronchiolitis (LB), sponsored by KU Leuven. Primary endpoints: Histology on bronchial and/or transbronchial biopsies at 3 months, Pulmonary function (FEV1) at 3 months and 2 more. Started Apr 2010; status: completed.
02
Drugs
azithromycin
03
Conditions
Lymphocytic bronchiolitis (LB)
Beyond the preview
Go deeper on NCT01109160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109160.